Ryan Montler

Title: Ryan Montler: Innovator in Cancer Treatment

Introduction

Ryan Montler is a notable inventor based in Camas, Washington. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the utilization of specific T cells for the identification and treatment of tumors.

Latest Patents

Ryan Montler holds a patent titled "Utilization of CD39 and CD103 for identification of human tumor reactive T cells for treatment of cancer." This patent outlines methods for treating subjects with tumors by administering a therapeutically effective amount of CD8CD39CD103 T cells. The methods also include isolating a nucleic acid encoding a T cell receptor (TCR) that specifically binds to tumor cell antigens. Furthermore, the patent describes techniques for expanding CD8CD39CD103 T cells and determining if a subject will respond to checkpoint inhibitors by detecting the presence of these T cells in biological samples.

Career Highlights

Throughout his career, Ryan has worked with prominent organizations such as Providence Health & Services in Oregon and Agonox, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Ryan has collaborated with notable colleagues, including Andrew D. Weinberg and Thomas Duhen. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Ryan Montler is a pioneering inventor whose work in cancer treatment has the potential to significantly impact patient care. His innovative methods and collaborations highlight his commitment to advancing medical science.